Validation of Epstein criteria of insignificant prostate cancer in Middle East patients

Ihab A. Hekal; Nasr A. El-Tabey; Mohamed Adel Nabeeh; Ahmed El-Assmy; Mohamed Abd El-Hameed; Adel Nabeeh; Elhousseiny I. Ibrahiem

首页> 外文期刊>International Urology and Nephrology >Validation of Epstein criteria of insignificant prostate cancer in Middle East patients

【24h】

Validation of Epstein criteria of insignificant prostate cancer in Middle East patients

机译：爱泼斯坦微不足道的前列腺癌在中东地区的标准的验证

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background Since introduction of Contemporary Epstein criteria, it has been studied and validated in many countries and nations. However, they were not validated in Middle East patients up till now.

机译：背景技术自从引入现代爱泼斯坦标准以来，它已经在许多国家和地区进行了研究和验证。但是，到目前为止，它们尚未在中东患者中得到验证。

著录项

来源
《International Urology and Nephrology》 |2010年第3期|p.667-671|共5页
作者
Ihab A. Hekal; Nasr A. El-Tabey; Mohamed Adel Nabeeh; Ahmed El-Assmy; Mohamed Abd El-Hameed; Adel Nabeeh; Elhousseiny I. Ibrahiem;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Validation of Epstein criteria of insignificant prostate cancer in Middle East patients. [J] . Hekal IA, El Tabey NA, Nabeeh MA, International Urology and Nephrology . 2010,第3期

机译：中东患者微不足道的前列腺癌的爱泼斯坦标准的验证。
2. Validation of the contemporary epstein criteria for insignificant prostate cancer in European men. [J] . Jeldres C, Suardi N, Walz J, European urology . 2008,第6期

机译：当代爱泼斯坦标准的欧洲男性微不足道的前列腺癌的验证。
3. Accuracy of the contemporary Epstein criteria to predict insignificant prostate cancer in North African Man [J] . A. Ammani, A. Janane, B. Bouzide, African journal of urology . 2016,第3期

机译：当代爱泼斯坦标准预测北非人微不足道的前列腺癌的准确性
4. Validation of a Quantifier-Based Fuzzy Classification System for Breast Cancer Patients on External Independent Cohorts [C] . Daniele Soria, Jonathan M. Garibaldi IEEE International Conference on Machine Learning and Applications . 2016

机译：基于量词的乳腺癌患者外部独立队列模糊分类系统的验证
5. Use and prevalence of Complementary and alternative medicine (CAM) by populations with specific needs: Patients with cancer, breast cancer, benign prostatic hyperplasia and asthma [D] . Borneman, John P. 2007

机译：特殊需要人群的补充和替代药物（CAM）的使用和流行：癌症，乳腺癌，良性前列腺增生和哮喘患者
6. Validation of revised Epstein’s criteria for insignificant prostate cancer prediction in a Greek subpopulation [O] . Κ Chondros, Ν Karpathakis, Ι Heretis, 2015

机译：修改后的爱泼斯坦标准对希腊亚人群中微不足道的前列腺癌预测的有效性
7. Validation of Epstein biopsy criteria for insignificant prostate cancer in contemporary cohort of Croatian patients. [O] . Tomašković Igor, Ulamec Monika, Tomić Miroslav, 2015

机译：在当代克罗地亚患者队列中验证Epstein活检标准对不显着的前列腺癌的影响。

Validation of Epstein criteria of insignificant prostate cancer in Middle East patients

摘要

著录项

相似文献

相关主题

期刊订阅